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Involvement of Fas-dependent apoptosis in renal tubular epi- trophy and hyperplasia, the molecular pathways regulat-
thelial cell deletion in chronic renal failure. Renal tubular atro- ing the transition from tubular hypertrophy to atrophy
phy predicts a poor prognosis in chronic renal failure, but remain unclear.the molecular mechanisms that regulate tubular atrophy are
The most prominent theory that has been forwardedunknown. Because the Fas apoptosis pathway has been impli-
to explain the pathogenesis of tubular atrophy is thatcated in disease pathogenesis and Fas is expressed in kidney,
we hypothesized that Fas-mediated renal tubule epithelial cell RTCs are subjected to chronic ischemia [6, 7]. However,
(RTC) apoptosis contributes to tubular atrophy in chronic re- ischemia commonly leads to necrosis, a pathologic fea-
nal failure. Immunohistochemical analyses of renal sections ture that is not typically observed in RTCs in most typesfrom two murine models of progressive renal disease revealed
of chronic renal disease. Furthermore, the processes thatincreases in RTC Fas expression and apoptosis compared with
render RTC susceptible to ischemic injury would be pri-tissue sections from age-matched control kidneys. Increased
RTC apoptosis was not accompanied by compensatory hyper- marily initiated by downstream effects of glomerular in-
plasia, suggesting that RTCs targeted for Fas-dependent apop- jury, such as obliteration of vasa recta blood supply [6],
totic deletion contribute to tubular atrophy. These data are
suggesting that the extent of tubular atrophy should par-supported by in vitro studies that showed that interleukin-1a or
allel glomerular pathology. However, tubulointerstitialtumor necrosis factor-a, cytokines that are secreted in chronic
renal failure, stimulated increases in Fas expression in cultured and glomerular histology are not tightly correlated [1, 2],
RTCs. Both murine kidney cortex and RTCs in culture demon- indicating that factors independent of the glomerulus
strated constitutive expression of Fas ligand, a feature that is contribute to the pathogenesis of tubular atrophy. In-characteristically restricted to lymphocytes and immune-privi-
deed, RTCs have been shown to independently regulateleged tissues and previously unrecognized in RTCs. Functional
fibrogenic effector pathways in response to injury [8].studies revealed that interleukin-1a–stimulated RTC Fas ex-
pression was accompanied by increased apoptosis, which was An alternative mechanism of tubular atrophy is apop-
inhibited by blocking anti-Fas ligand antibodies. The data sug- tosis, which has recently been shown to mediate the
gest that up-regulated RTC Fas binds to Fas ligand on adjacent
pathogenesis of many diseases [9], including RTC deathRTCs, which then leads to RTC death by fratricide. We propose
[10–13]. The Fas apoptosis pathway is initiated by bind-this pathway as an initiating mechanism of tubular atrophy.
ing of Fas ligand (FasL) to Fas, which triggers a cascade
of intracellular signals that results in apoptotic deletion
of Fas-bearing target cells [14]. Constitutive Fas expres-The pathogenesis of chronic renal failure is initiated
sion has been demonstrated in RTC [15], and Ortiz-by glomerular injury in most instances, but it has been
Arduan et al have recently shown that RTC Fas expres-documented for 25 to 30 years that tubular atrophy,
sion and function are up-regulated by cytokines in vitrowhich is merely a pathologic description for the absence
and in an in vivo endotoxic shock model of acute renalof renal tubule epithelial cells (RTCs), is a better pre-
failure [16]. The role of Fas-dependent RTC apoptosisdictor of renal disease progression than glomerular pa-
was investigated as a potential molecular pathogeneticthology [1–3]. Although tubular atrophy is clearly an
important marker of progression, tubular hypertrophy mechanism of tubular atrophy in this study.
is a common early finding in chronic renal disease, partic-
ularly in diabetic nephropathy [4, 5]. Despite intensive
METHODSinvestigation regarding the mechanisms of RTC hyper-
Apoptosis assay in kidney tissue
Apoptotic RTC nuclei were detected in kidney frozenKey words: tubular atrophy, cell death, chronic renal failure, diabetic
nephropathy. sections from FVB/N-p53 [17] and ROP-Os/1 [18]
mouse models of progressive renal disease by the immu- 1999 by the International Society of Nephrology
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nofluorescence TUNEL technique [19] according to
manufacturer’s instructions (Oncor, Gaithersburg, MD,
USA). Kidney sections were incubated with TdT and
digoxigen-labeled dUTP and then with FITC-conjugated
anti-digoxigen IgG. Positive controls for apoptosis were
mouse thymus, and negative controls were kidney sec-
tions incubated without TdT. The prevalence of apopto-
sis was defined as the ratio of TUNEL-positive RTC
to total RTC nuclei (as determined by Hoechst 33258
labeling).
Immunoblot methods
Methods have previously been described in detail [20].
Fig. 1. Time course and prevalence of apoptotic renal tubular cellsBriefly, kidney cortex was lyzed and denatured with boil-
(RTCs) in vivo. Prevalence of RTC apoptosis was determined in FVB/ing sodium dodecyl sulfate-polyacrylamide gel electro-
N-1/1 (h) and FVB/N-p53 ( ) mouse kidneys at depicted time points.
phoresis (SDS-PAGE) buffer (125 mm Tris, pH 6.8, Results are expressed as the mean percentage of apoptotic RTC 6 sem.
Data are representative of three experiments.2% SDS, 5% glycerol, 1% b-mercaptoethanol, 0.003%
bromphenol blue) for five minutes. Samples (50 mg/lane)
were resolved by 12% SDS-PAGE and transferred to
polyvinylidine difluoride (PVDF) membranes. Blots
were probed with anti-Fas IgG (1 mg/ml, one hour, room
temperature) and then with peroxidase-conjugated IgG
(1:5000, one hour, room temp). Band intensity was de-
tected by enhanced chemiluminescence.
Detection of apoptotic cells by flow cytometry
Human renal proximal tubular (HRPT) cells were de-
Fig. 2. Increased Fas expression in cortex from murine chronic renalrived from human proximal RTCs, immortalized by ad-
disease models. Renal cortex lysates from age-matched control (ROP-
eno-12/SV40 transformation, and maintained in DMEM- 1/1) and ROP-Os /1 mice, as well as age-matched control (FVB/N-
1/1) and FVB/N-p53 mice were resolved by SDS-PAGE and probedF12 1 5% fetal bovine serum (FBS) [21]. Cells were
for Fas by immunoblot analysis using rabbit anti-mouse Fas IgG aspreincubated with or without interleukin (IL)-1a (20 ng/ml,
described in the Methods section. Data are representative of two experi-
24 hr, 378C). Fas was clustered and activated by co-incu- ments.
bating HRPT cells with agonistic mouse anti-human Fas
IgM (CH11 clone, 150 ng/ml, 16 hr, 378C), fixed in 1%
paraformaldehyde, and lifted with 5 mm ethylenediamine-
expression of Fas in both ROP-Os/1 and FVB/N-p53tetraacetic acid (EDTA). Apoptotic HRPTs were detected
mice compared with age-matched controls. The mecha-by the immunofluorescence TUNEL technique and flow
nism of Fas overexpression is undoubtedly complex, ascytometry as previously described [22]. Background flu-
IL-1a, tumor necrosis factor (TNF), and hypoxia eachorescence was established in HRPT cells incubated with
stimulated Fas expression in cultured RTCs (data notPBS alone, isotype control antibodies, or without TdT.
shown). Because apoptosis and Fas up-regulation coex-Positive controls were SKW6.4 lymphocytes. Data are
isted at time points prior to the onset of widespreadexpressed as the percentage of apoptotic cells, which was
tubular atrophy, the data suggested that RTCs are tar-calculated by determining the percentage of gated cells
geted for Fas-dependent apoptotic deletion, and this pro-with fluorescence that exceeded background levels.
cess contributes to tubular atrophy. These studies also
indicate that, in addition to known proinflammatory ef-
RESULTS fects of IL-1 and TNF, these cytokines may indirectly pro-
Using immunohistochemical techniques, increases in mote tubular atrophy via Fas-dependent RTC apoptosis.
RTC apoptosis were observed at multiple time points in Surprisingly, both murine kidney cortex and RTCs in
ROP-Os/1 and FVB/N-p53 mice compared with tissue culture demonstrated constitutive expression of RTC FasL
sections from age-matched control kidneys (Fig. 1). The (data not shown), a feature that was previously assumed
prevalence of apoptotic RTCs from Os/1 kidneys ranged to be restricted primarily to lymphocytes and immune-
from 0.2 to 0.7%, with no compensatory RTC hyperpla- privileged tissues and was unrecognized in RTCs. Fur-
sia in diseased kidneys (by PCNA staining, data not thermore, RTC Fas overexpression in conjunction with
constitutive RTC FasL expression raised the possibilityshown). Figure 2 demonstrates increased kidney cortex
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Table 1. Renal tubular cells (RTC) undergo Fas-dependent RTCs. Although previous reports have demonstrated
fratricidal apoptosis
basal kidney Fas expression [15], a unique finding in
Incubation conditions % Apoptotic RTC the current studies is enhanced RTC Fas expression in
No additions 1.6 60.3 chronic renal failure. The observation that RTC Fas ex-
Anti-FasL IgG 0.7 60.1 pression was increased in vivo does not contradict the
IL-1 16.361.4
conventional paradigm whereby Fas-expressing cells un-IL-1 1 anti-FasL IgG 1.560.3a
IL-1 1 isotype control IgG 16.4 65.0 dergo apoptosis following binding to lymphocyte FasL.
However, in vivo and in vitro data demonstrated FasLHuman renal proximal tubule cells (HRPT) were cultured in serum-free media
for 48 hr 6 IL-1 (20 ng/ml, 24 hr, 378C) 6 blocking anti-human FasL antibodies expression in RTCs, a finding that has heretofore been
(anti-FasL, 10 mg/ml, 24 hr, 378C). Apoptotic cells were detected by immunofluo-
restricted primarily to lymphocytes and immune-privi-rescence TUNEL and flow cytometry as described in the Methods section. Re-
sults are expressed as mean % apoptotic cells above background (fluorescence leged tissues. Therefore, up-regulation of RTC Fas, inin HRPT with TdT omitted in the TUNEL assay) 6 sem. Data are representative
of four experiments. conjunction with constitutive RTC membrane FasL ex-
a P , 0.05 by ANOVA compared to IL-1 or IL-1 1 isotype control IgG groups pression, increases the probability of RTC Fas-RTC
FasL binding. This interaction could then result in lym-
phocyte-independent “suicide” or “fratricide” [23]. Our
in vitro data support this type of Fas-dependent RTCof a Fas–FasL interaction between adjacent cells, resulting
death; blocking anti-FasL antibodies had no effect onin lymphocyte-independent “fratricidal” RTC apoptosis,
baseline RTC apoptosis, indicating that low-level basalas previously described in the pathogenesis of alcoholic
RTC Fas expression was insufficient for functional Fas–cirrhosis and autoimmune thyroiditis [23, 24]. Functional
FasL interaction between RTCs. However, IL-1 induc-studies in cultured RTCs revealed that IL-1 stimulated
tion of RTC Fas expression was associated with increasedincreased apoptosis, which was inhibited by co-incubation
apoptosis, which was inhibited by blocking anti-FasLwith blocking anti-FasL antibodies (Table 1), indicating
antibodies. These data suggest that enhanced RTC Fasthat Fas-dependent RTC fratricide is a plausible mecha-
expression increases the likelihood of Fas-FasL binding,nism of tubular atrophy.
which promotes RTC deletion by fratricide.
In conclusion, we have provided evidence in murine
DISCUSSION models of chronic renal failure that RTCs are induced to
Although it has been recognized for decades that tubu- express Fas, constitutively synthesize FasL, and undergo
lar atrophy is one of the most accurate pathologic pre- apoptosis by Fas-dependent fratricide. Because apopto-
dictors of renal disease progression [1, 2], the molecular sis may represent a final common RTC death pathway
mechanisms that regulate this process remain unclear. and tubular atrophy is a strong predictor of disease pro-
We demonstrated that RTCs undergo increased apopto- gression, we speculate that efforts to abort Fas-depen-
sis in two murine models of progressive chronic renal dent RTC apoptosis may contribute to improved progno-
failure, suggesting that apoptotic RTC deletion contrib- sis in diseases where definitive treatment is not currently
utes to tubular atrophy. These data are in agreement available.
with previous reports of RTC apoptosis in both animals
and humans with chronic renal disease [10, 12, 13, 25]. ACKNOWLEDGMENTS
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